About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
CNS Drugs
›
Top Articles
CNS Drugs
Psychiatry
,
Neurology
,
Pharmacology
,
Clinical Neurology
6.7
(top 2%)
Impact Factor
7.2
(top 2%)
extended IF
114
(top 3%)
H-Index
1.4K
authors
2.4K
papers
77.3K
citations
5.8K
citing journals
40.5K
citing authors
Most Cited Articles of CNS Drugs
Title
Year
Citations
Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review
2005
662
Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention
2005
522
Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy
2002
463
Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience
2002
454
Internet addiction: definition, assessment, epidemiology and clinical management
2008
392
Neuropsychiatric adverse effects of interferon-alpha: recognition and management
2005
357
Cognitive effects of long-term benzodiazepine use: a meta-analysis
2004
343
Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence
2013
329
Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia
2006
315
The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment
2003
295
Getting into the brain: approaches to enhance brain drug delivery
2009
294
Suicidal behaviour in bipolar disorder: risk and prevention
2003
292
Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics
2008
288
Adverse effects of atypical antipsychotics : differential risk and clinical implications
2007
286
Smoking cessation in women. Special considerations
2001
264
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management
2010
263
Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction
2009
260
Zolpidem: a review of its use in the management of insomnia
2005
256
Potential mechanisms of action of lithium in bipolar disorder. Current understanding
2013
236
Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders
2004
234
Mechanism of action of St John's wort in depression : what is known?
2003
234
Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy
2008
233
Dopamine partial agonists: a new class of antipsychotic
2004
222
Benzodiazepines and risk of hip fractures in older people: a review of the evidence
2003
221
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications
2001
219
previous
2014
2015
2016
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.